Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693251015 | Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693253017 | Fluocortolone hexanoate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing fluocortolone in topical dosage form | false | Inferred relationship | Some | ||
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing fluocortolone hexanoate and fluocortolone pivalate | false | Inferred relationship | Some | ||
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Fluocortolone pivalate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Fluocortolone hexanoate (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Fluocortolone hexanoate (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Fluocortolone pivalate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Fluocortolone only product in cutaneous dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets